Tag Archives: AKRX

Best Stocks To Buy Right Now

China Mobile Ltd. (NYSE: CHL) is the world’s largest mobile company. It has 900 million subscribers, almost three times the U.S. population. The company is owned by the Chinese government. The Trump administration wants to block its ability to do business in America, another casualty of an effort to keep Chinese technology companies from tapping into U.S. intellectual property.

The administration petitioned the FCC in a filing:

After significant engagement with China Mobile, concerns about increased risks to U.S. law enforcement and national security interests were unable to be resolved. Therefore, the Executive Branch of the U.S. government, through the National Telecommunications and Information Administration pursuant to its statutory responsibility to coordinate the presentation of views of the Executive Branch to the FCC, recommends that the FCC deny China Mobiles Section 214 license request.

China Mobile’s petitions to do business in the United States date back to 2013.

Best Stocks To Buy Right Now: GlaxoSmithKline PLC(GSK)

Advisors’ Opinion:

  • [By Cory Renauer]

    Around a year ago, the partners launched an eczema drug that’s already surpassed Praluent on the sales charts, and a possible expansion to asthma could send Dupixent sales through the roof.In studies supporting an application under review at the moment, Dupixent reduced severe attacks by up to 67% for some patients with uncontrolled asthma. It also led to lung function measurements that suggest it can compete with GlaxoSmithKline’s (NYSE:GSK)Nucula for a slice of a global market for asthma treatments expected to reach $56.5 billion by 2025.

  • [By Ethan Ryder]

    GlaxoSmithKline (NYSE:GSK) was the target of unusually large options trading on Thursday. Investors purchased 29,143 call options on the stock. This represents an increase of 938% compared to the average daily volume of 2,808 call options.

  • [By Sean Williams, Chuck Saletta, and Brian Feroldi]

    Unlike most drug developers, Innoviva is a royalty-based company. Having spun off Theravance BioPharmayears ago, Innoviva now sits back and collects royalties on the net sales of long-lasting COPD and asthma therapies jointly developed with GlaxoSmithKline (NYSE:GSK). You probably know these drugs as Breo Ellipta, Anoro Ellipta, and the newly approved Trelegy Ellipta.

  • [By Cory Renauer]

    The fifth most valuable research and development project right now belongs to GlaxoSmithKline (NYSE:GSK) and it’s so fresh it doesn’t even have a proper name yet. GSK2857916 is a fancy protein bound to a lethal dose of chemo that it only releases when it finds its target. In this candidate’s case, the target is beta-cell maturation antigen, a protein often found on the surface of cancer cells in people with multiple myeloma.

  • [By Keith Speights]

    It’s been a very different year so far for two big pharma stocks: One’s hot and one’s not. Things are going great for GlaxoSmithKline plc(NYSE:GSK)as its share price is up around 15% year to date. But for Johnson & Johnson (NYSE:JNJ), it’s a different story. J&J stock is down more than 10% in 2018.

  • [By Keith Speights]

    GlaxoSmithKline (GSK), like Teva, lost ground last year, with its stock declining by nearly 8%. So far in 2018, though, GSK’s share price is up more than 12% — trouncing the major indexes.

Best Stocks To Buy Right Now: Akorn, Inc.(AKRX)

Advisors’ Opinion:

  • [By Paul Ausick]

    Akorn Inc. (NASDAQ: AKRX) dropped nearly 40% Tuesday to post a new 52-week low of $18.20. Shares closed at $30.28 on Monday and the stock’s 52-week high is $34.00. Volume was nearly 22 million, more than 20 times the daily average. A potential acquirer has announced an investigation into possible data breaches. 247wallst.com/healthcare-business/2018/02/27/could-data-breaches-break-up-the-akorn-aquisition/

  • [By Joseph Griffin]

    Akorn (NASDAQ:AKRX) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in a note issued to investors on Monday.

  • [By Chris Lange]

    Akorn Inc. (NASDAQ: AKRX) shares were crushed on Monday (although not as bad as at Prothena)after it was announced that the German firm Fresenius would no longer be purchasing Akorn. Fresenius noted that this was the result of alleged breaches and data integrity requirements. However, Akorn intends to fight this, but who will win is still yet to be seen.

Best Stocks To Buy Right Now: H&R Block, Inc.(HRB)

Advisors’ Opinion:

  • [By Demitrios Kalogeropoulos]

    The week ahead will likely bring more volatility, particularly for shareholders ofDave & Buster’s(NASDAQ:PLAY), H&R Block(NYSE:HRB), and Michaels(NASDAQ:MIK)as each of these companies is set to announce quarterly earnings results over the next few days. Let’s look at a few key trends to watch for in the reports.

  • [By Ethan Ryder]

    H & R Block Inc (NYSE:HRB) Director Robert A. Gerard acquired 1,000 shares of the firm’s stock in a transaction dated Friday, June 22nd. The shares were purchased at an average price of $23.18 per share, for a total transaction of $23,180.00. Following the completion of the transaction, the director now directly owns 148,579 shares in the company, valued at $3,444,061.22. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

  • [By Stephan Byrd]

    H&R Block (NYSE:HRB) saw some unusual options trading on Monday. Stock traders purchased 13,239 call options on the company. This represents an increase of approximately 1,694% compared to the average daily volume of 738 call options.

  • [By Joseph Griffin]

    TheStreet upgraded shares of H & R Block (NYSE:HRB) from a c+ rating to a b rating in a report released on Tuesday.

    Other equities research analysts have also issued research reports about the company. Barrington Research lowered their price objective on H & R Block from $32.00 to $27.00 and set an outperform rating for the company in a research note on Thursday. ValuEngine downgraded H & R Block from a sell rating to a strong sell rating in a report on Wednesday. Morgan Stanley reaffirmed an equal weight rating and set a $28.00 target price (up previously from $27.00) on shares of H & R Block in a report on Wednesday, March 7th. BMO Capital Markets reduced their target price on H & R Block from $29.00 to $25.00 and set a market perform rating on the stock in a report on Wednesday. Finally, Zacks Investment Research downgraded H & R Block from a strong-buy rating to a hold rating in a report on Tuesday, March 27th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the stock. H & R Block presently has a consensus rating of Hold and a consensus price target of $26.21.

  • [By Paul Ausick]

    H&R Block Inc. (NYSE: HRB) traded down about 1.2% Tuesday and posted a new 52-week low of $23.28 after closing Monday at $23.55. The stock’s 52-week high is $31.80. Volume totaled about 3.1 million, about a third higher than the daily average of around 3.2 million. The company had no specific news. Shares have turned around and are headed for a gain of about 1.4% at the closing bell.

  • [By Garrett Baldwin]

    Today, Bill offers our readers a few of his favorites as Trump meets with Kim Jong Un.Here’s how to cash in regardless of how this summit turns out in the long run.

    The Top Stock Market Stories for Tuesday
    Last night, President Trump met North Korean leader Kim Jong Un in Singapore. This was the first meeting between a sitting American president and a North Korean leader. Following the agreement, analysts noted that the document signed by both parties included no concrete details for achieving denuclearization on the Korean Peninsula. Trump responded to criticism by saying he is fully confident that the Korean dictatorship will follow through. A U.S. district court will rule on whether to approve an $85 billion merger between AT&T Inc. (NYSE: T) and Time Warner Inc. (NYSE: TWX). The decision comes after about six weeks of debate in a courtroom. The ruling will likely have a significant impact on the proposed bid by The Walt Disney Co. (NYSE: DIS) for media giant Twenty-First Century Fox Inc.(NYSE: FOXA). The Fed Open Market Committee kicks off its June meeting today. The U.S. central bank is expected to raise interest rates for the second time in 2018. On Wednesday, U.S. Federal Reserve Chair Jerome Powell will likely announce a hike of 0.25% to the benchmark rate to 2%. This would also mark the seventh hike since December 2015. Markets will be looking for clues during Powell’s conference to determine how many additional times the Fed plans to raise interest rates during the final six months of the year.
    Three Stocks to Watch Today: RH, TSLA, GE
    Restoration Hardware Holdings Inc. (NYSE: RH) stock popped more than 20% in pre-market hours after the company reported very strong profits for the quarter. The retailer reported earnings per share of $1.33, well above the $1.02 anticipated by analysts. The company also reported a strong second-quarter outlook, news that reduced concerns about it falling short of revenue expectations. Tesla Inc. (Nasdaq: TS

Best Stocks To Buy Right Now: Wendy’s/Arby’s Group Inc.(WEN)

Advisors’ Opinion:

  • [By ]

    Throughout its history, Starbucks has mostly had a company-owned model for its retail locations, a strategy that is at odds with a trend of activist investors pushing fast food, restaurant and coffee companies to franchise locations out to raise cash for stock buybacks and debt reduction. In recent years, activists have targeted Jamba Juice (JMBA) , Potbelly (PBPB) , Jack in the Box (JACK) , Wendys Co. (WEN) , McDonald’s (MCD) and elsewhere. In addition, Starbucks has a one-share, one-vote structure, which can make it vulnerable to an activist investor seeking to elect dissident director candidates as it pursued the strategy.

  • [By Stephan Byrd]

    Wendys (NASDAQ: WEN) and Empire Resorts (NASDAQ:NYNY) are both retail/wholesale companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

  • [By Logan Wallace]

    Wendy’s (NASDAQ:WEN) major shareholder Edward P. Garden sold 764,000 shares of the business’s stock in a transaction dated Tuesday, May 15th. The stock was sold at an average price of $16.53, for a total value of $12,628,920.00. Following the completion of the sale, the insider now directly owns 240,365 shares of the company’s stock, valued at approximately $3,973,233.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

  • [By ]

    In the Lightning Round, Cramer was bullish on Spirit AeroSystems (SPR) , Take-Two Interactive (TTWO) , Dunkin Brands (DNKN) and Wendy’s (WEN) .

    Cramer was bearish on Bristol-Myers Squibb (BMY) and Univar (UNVR) .

  • [By Matt Hogan]

    Growth within the industry is a bit lumpy, with limited-service restaurants, such as Wendys Co (NASDAQ: WEN) and Chipotle Mexican Grill, Inc (NYSE: CMG), growing at 5.3 percent in 2017 as compared to 3.5 percent for casual dining establishments according to the National Restaurant Industry.

  • [By Leo Sun]

    However, the fast casual market became increasingly crowded with rival chains like Panera Bread and Chipotle, and Zoe’s got squeezed between traditional dine-in restaurants like Darden’s Olive Garden and evolving fast food players like Wendy’s (NASDAQ:WEN) and McDonald’s (NYSE:MCD).

Best Stocks To Buy Right Now: U.S. Silica Holdings, Inc.(SLCA)

Advisors’ Opinion:

  • [By Tyler Crowe]

    U.S. Silica Holdings (NYSE:SLCA) has long been the standout company in the frack sand business. Its size and financial strength allowed it to weather the drop in oil prices better than its peers and positioned it well for the recent growth phase. This past quarter, the company expanded its universe by acquiring another mineral mining business, but it is taking some risk in doing this. Thankfully, demand for frack sand remains high, as evidenced by the company’s most recent earnings results.

  • [By Ethan Ryder]

    U.S. Silica (NYSE: SLCA) and Fairmount Santrol (NYSE:FMSA) are both basic materials companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation and dividends.

  • [By Jason Hall, Tyler Crowe, and John Bromels]

    Three Motley Fool energy experts have already put in the work to help you get started, having identified integrated oil and gas super-major Royal Dutch Shell plc (ADR)(NYSE:RDS-A)(NYSE:RDS-B), surprisingly diverse sand supplierU.S. Silica Holdings Inc(NYSE:SLCA), and still-cheap, still-strong wind turbine leaderVestas Wind Systems(NASDAQOTH:VWDRY).Keep reading for unique, real-investor insight on what makes these three energy stocks worth buying this month.

Best Blue Chip Stocks To Buy Right Now

The stock market gave up ground on Tuesday, but investors saw major benchmarks recover from their worst levels of the day to finish down less than half a percent. Early in the day, poor earnings results from blue chip components of the Dow Jones Industrials weighed on market sentiment, and ongoing uncertainty about whether the Trump administration will be able to deliver on promised government reforms made some investors feel less confident about the future. However, several companies reported good news despite the dour mood on Wall Street, and GNC Holdings (NYSE:GNC), Stratasys (NASDAQ:SSYS), and Cabela’s (NYSE:CAB) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

GNC eases shareholders’ concerns

Shares of GNC Holdings jumped 24% after the company posted first-quarter results that, while not perfect, were still not as bad as some investors had feared. Revenue fell 4% from year-ago levels, and same-store sales dropped 3.9% in company-owned locations and 4.6% in domestic franchise stores. Moreover, net income dropped by more than half, leaving the company with just $0.37 per share in adjusted earnings. Yet those numbers encouraged those who are patient enough to give GNC time to remake itself, and CEO Bob Moran pointed to the company’s One New GNC transformation strategy as having shown signs of early success. With new loyalty programs producing some positive effects on transaction counts and volume, GNC hopes that business metrics will hit bottom and start to grow again in the near future.

Best Blue Chip Stocks To Buy Right Now: Nam Tai Electronics Inc.(NTE)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another stock that’s starting to move within range of triggering a big breakout trade is Nam Tai Electronics (NTE), which is an electronics manufacturing and design services provider to a select group of the world’s leading OEMs of telecommunications and consumer electronic products. This stock has been destroyed by the sellers so far in 2013, with shares off sharply by 41%.

    If you look at the chart for Nam Tai Electronics, you’ll notice that this stock has been uptrending for the last month and change, with shares moving higher from its low of $6.05 to its recent high of $8.38 a share. During that uptrend, shares of NTE have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of NTE within range of triggering a big breakout trade.

    Traders should now look for long-biased trades in NTE if it manages to break out above some key near-term overhead resistance levels at $8.38 to $8.79 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 647,483 shares. If that breakout triggers soon, then NTE will set up to re-fill some of its previous gap down zone from April that started near $11.50 a share. If this stock gets into that gap with volume, then the upside is tremendous and we could easily see NTE hit $11 to $12 a share.

    Traders can look to buy NTE off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $7.42 a share, or below more key support at $7.22 a share. One can also buy NTE off strength once it takes out that breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Best Blue Chip Stocks To Buy Right Now: CyberArk Software Ltd.(CYBR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Citigroup Inc (NYSE: C) to report quarterly earnings at $1.26 per share on revenue of $17.71 billion before the opening bell. Citigroup shares rose 0.30 percent to $67.22 in after-hours trading.
    Analysts are expecting JPMorgan Chase & Co. (NYSE: JPM) to have earned $1.65 per share on revenue of $25.61 billion in the latest quarter. JPMorgan will release earnings before the markets open. JPMorgan shares gained 0.48 percent to $93.55 in after-hours trading.
    Cyberark Software Ltd (NASDAQ: CYBR) lowered its guidance for the second quarter. The company now expects total revenue of $57.0 million to $57.5 million, versus earlier guidance of $61.0 million to $62.0 million. Cyberark shares dipped 17.65 percent to $42.00 in the after-hours trading session.
    Before the opening bell, First Republic Bank (NYSE: FRC) is projected to report quarterly earnings at $1.1 per share on revenue of $675.70 million. First Republic Bank shares dropped 0.80 percent to close at $101.35 on Thursday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Joe Tenebruso]

    CyberArk Software (NASDAQ:CYBR) reported fourth-quarter financial results on Feb. 9. The Israeli cybersecurity specialist continues to win new business for its “privileged account” security solutions, which help to protect against cyberattacks that use insider privileges to penetrate network perimeters and assault the most sensitive areas of an enterprise’s IT infrastructure.

Best Blue Chip Stocks To Buy Right Now: Akorn, Inc.(AKRX)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Shares of Endo International (ENDP) have tumbled 40% today after it said profits would fall well short of analyst expectations thanks, in part, to plunging generic drug prices. Leerink’s Jason Gerberry and team look for specialty pharmaceutical companies that have similar business models–and find Akorn (AKRX), Perrigo (PRGO), and Teva Pharmaceutical Industries (TEVA). They explain:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 0.62 percent. Meanwhile, top losers in the sector included Akorn, Inc. (NASDAQ: AKRX), down 17 percent, and BioDelivery Sciences International, Inc. (NASDAQ: BDSI), down 14 percent.

  • [By Wayne Duggan]

    Akorn, Inc. (NASDAQ: AKRX) shares are drifting higher by 0.27 percent (about $0.10 per share) Wednesday after jumping 3.2 percent Tuesday following a report the company was on the verge of a buyout deal.

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

  • [By Wayne Duggan]

    Akorn, Inc. (NASDAQ: AKRX) shares are up 18.2 percent on Friday after Bloomberg reported Frensius is considering a buyout bid for Akorn.

    The news came just hours after Benzinga alerted its pro subscribers to an unusually large Akorn call purchase on the options market.

  • [By Dan Caplinger]

    Despite a lack of conviction in the market at large, some stocks posted sharp gains on Friday, and Diana Shipping (NYSE:DSX), Akorn (NASDAQ:AKRX), and Granite Construction (NYSE:GVA) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

Best Blue Chip Stocks To Buy Right Now: ZELTIQ Aesthetics, Inc.(ZLTQ)

Advisors’ Opinion:

  • [By James E. Brumley]

    This week, Botox maker Allergan plc (NYSE:AGN) shelled out $2.5 billion for body-sculpting outfit Zeltiq Aesthetics Inc (NASDAQ:ZLTQ). The pairing is a nice opportunity for both organizations to cross-sell to one another’s customers. Allergan’s Botox customers seeking a more youthful face will also likely want the better body Zeltiq Aesthetics provides, and Zeltiq Aesthetics’ customers are natural candidates for Botox injections that Allergan facilitates.

    The acquisition, though, is just a microcosm of a bigger trend that’s still picking up steam. That trend is, as the industry’s capabilities to restore youth, slim waists, whiten teeth, improve skin, and nip and tuck here and there improve with science, demand for these increasingly effective ‘tweaks’ is soaring. Names like the aforementioned Allergan, Cynosure, Inc. (NASDAQ:CYNO), Zeltiq Aesthetics and Align Technology, Inc. (NASDAQ:ALGN) are all driving impressive growth. And, they’re all looking to expand their footprint in front of the rising tide.

    Not every name riding this growth wave is going to be a large cap stock or a household name though. There’s a small cap stock called RepliCel Life Sciences (OTCMKTS:REPCF, CVE:RP) that could soon be turning a lot of heads not just of investors, but of potential suitors.

    In simplest terms, RepliCel Life Sciences has two key sciences that serve as the foundation for three therapies and one medical device.

    The first of the two biological premises is based on the company’s non-bulbar dermal sheath fibroblast platform, and currently includes treatments for chronic tendinosis and skin aging. The second is the company’s dermal sheath cup (DSC) cell platform for the treatment of androgenetic alopecia (pattern baldness).

    The three marketable products those two sciences are driving are RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair regeneration. The device is a dermal injector – currently categorized as R

Best Blue Chip Stocks To Buy Right Now: Renesola Ltd.(SOL)

Advisors’ Opinion:

  • [By Monica Gerson]

    ReneSola Ltd. (ADR) (NYSE: SOL) is estimated to report a quarterly loss at $0.04 per share on revenue of $256.05 million.

    America’s Car-Mart, Inc. (NASDAQ: CRMT) is projected to post its quarterly earnings at $0.58 per share on revenue of $149.13 million.

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
  • [By Monica Gerson]

    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 9.76 percent to $1.35 in pre-market trading. ReneSola reported Q1 earnings of $0.06 per share on revenue of $260.7 million.

  • [By Monica Gerson]

    Wall Street expects ReneSola Ltd. (ADR) (NYSE: SOL) to report a quarterly loss at $0.04 per share on revenue of $256.05 million. ReneSola shares gained 2.50 percent to close at $1.23 on Friday.

Best Blue Chip Stocks To Buy Right Now: Hatteras Financial Corp(HTS)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Hatteras Financial (HTS) has jumped 9.4% to $15.60 after agreeing to be purchased byAnnaly Capital Management (NLY) for $1.5 billion.Annaly Capital Management has dropped 1.1% to $$10.30.

stock forum

Streaming media company Roku will likely have an initial public offering before the end of the year, adding another public company to a crowded field. Rumors are Roku is worth about $1 billion

The Congressional Budget Office (CBO) reports that Trump will not be able to balance the U.S. budget for a decade based on the president’s current plans.

Online fantasy betting sites DraftKings and FanDuel will not merge as expected. Both have faced regulatory problems and rising marketing costs. It was assumed that the two very similarcompanies could save money by eliminatingduplicate costs

Honda Motor Co. Ltd. (NYSE: HMC) recalled 1.2 million Accord models. According to the AP:

Honda is recalling 1.2 million Accord midsize cars in the U.S. because a battery sensor can short out and potentially cause a fire.

The recall covers cars from the 2013 through 2016 model years. Honda says it has four reports of engine compartment fires due to the problem but no injuries. All the fires were in states where salt is used to clear roads in the winter.

stock forum: Ormat Technologies, Inc.(ORA)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of U.S. Geothermal back in positive territory while potential peer mid cap Calpine Corporation (NYSE: CPN) is underperforming and Ormat Technologies, Inc (NYSE: ORA) has been taking off for two years:

stock forum: Akorn, Inc.(AKRX)

Advisors’ Opinion:

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

  • [By Wayne Duggan]

    Akorn, Inc. (NASDAQ: AKRX) shares are up 18.2 percent on Friday after Bloomberg reported Frensius is considering a buyout bid for Akorn.

    The news came just hours after Benzinga alerted its pro subscribers to an unusually large Akorn call purchase on the options market.

  • [By Dan Caplinger]

    Despite a lack of conviction in the market at large, some stocks posted sharp gains on Friday, and Diana Shipping (NYSE:DSX), Akorn (NASDAQ:AKRX), and Granite Construction (NYSE:GVA) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 0.62 percent. Meanwhile, top losers in the sector included Akorn, Inc. (NASDAQ: AKRX), down 17 percent, and BioDelivery Sciences International, Inc. (NASDAQ: BDSI), down 14 percent.

  • [By Ben Levisohn]

    Shares of Endo International (ENDP) have tumbled 40% today after it said profits would fall well short of analyst expectations thanks, in part, to plunging generic drug prices. Leerink’s Jason Gerberry and team look for specialty pharmaceutical companies that have similar business models–and find Akorn (AKRX), Perrigo (PRGO), and Teva Pharmaceutical Industries (TEVA). They explain:

  • [By Wayne Duggan]

    Akorn, Inc. (NASDAQ: AKRX) shares are drifting higher by 0.27 percent (about $0.10 per share) Wednesday after jumping 3.2 percent Tuesday following a report the company was on the verge of a buyout deal.

stock forum: C.H. Robinson Worldwide, Inc.(CHRW)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) were down 4 percent to $71.69. UBS downgraded C.H. Robinson Worldwide from Neutral to Sell.

  • [By Gary Jakacky]

    Only one company convincingly jumped thru all the hoops: C.H. Robinson Worldwide, Inc. (CHRW).

    If only one of the companies in IYT appear to be undervalued, it might give you pause about how brightly the ETF will shine in the very near future.

  • [By Chad Tracy]

    As it's known today, C.H. Robinson (Nasdaq: CHRW) has again changed with the times.

    Unlike transportation industry titans FedEx (NYSE: FDX) or UPS (NYSE: UPS), C.H. Robinson does not own a fleet of trucks that transport goods. Instead, it specializes in logistics. Other companies hire C.H. Robinson to make their transportation services more efficient.

stock forum: Uranium Resources, Inc.(URRE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Uranium Resources, Inc. (NASDAQ: URRE) was down, falling around 12 percent to $2.37 after the company reported a closing of $9.7 million public offering.

  • [By Lisa Levin]

    Uranium Resources, Inc. (NASDAQ: URRE) shares dropped 19 percent to $2.55 after the company reported the pricing of $9.7 million public offering.

Best Gold Stocks For 2018

Keith Fitz-Gerald

With the focus still on North Korea, many investors are seeking refuge in gold.

But as Money Morning Chief Investment StrategistKeith Fitz-Gerald warns, “that train has already left the station.” Instead, here’s a better way to grow your money that most analysts haven’t even considered yet.

Additionally, in another round of dumb policy, Treasury Secretary Steve Mnuchin proposed cutting trade with any country that trades with North Korea. This proposed embargo would not only devastate relations with China, but would cost average Americans billions.

Here’s what you need to know…

Video 

Urgent: An $80 billion cover up? Feds use obscure loophole to threaten retirees Read more

The post Steve Mnuchin Will Cost Americans $600 Billion appeared first on Total Wealth.

Best Gold Stocks For 2018: Treehouse Foods, Inc.(THS)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Treehouse Foods (THS) , TG Therapeutics (TGTX) , Kinder Morgan (KMI) , Magellan Midstream Partners (MMP) , Chesapeake Energy (CHK) and Arconic (ARNC) .

Best Gold Stocks For 2018: Golden Ocean Group Limited(GOGL)

Advisors’ Opinion:

  • [By Ben Levisohn]

    StarBulk Carriers (SBLK) and Safe Bulkers (SB) have more than tripled during the past 12 months, while Golden Ocean Group (GOGL) has more than doubled. So it must be time for an upgrade right?

Best Gold Stocks For 2018: Capricor Therapeutics, Inc.(CAPR)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Marathon Patent Group Inc (NASDAQ: MARA) shares surged 30.2 percent to $5.01 after dropping 40.86 percent on Tuesday. Marathon Patent Group filed for sale of 1.85 million shares of common stock by selling stockholders.
    Capricor Therapeutics Inc (NASDAQ: CAPR) shares jumped 17.2 percent to $2.25 after the company reported the FDA clearance of Investigational New Drug application for CAP-1002.
    Rite Aid Corporation (NYSE: RAD) gained 13.2 percent to $2.15 following 16.5 percent rally on Tuesday.
    Photronics, Inc. (NASDAQ: PLAB) shares climbed 11.8 percent to $10.45 after the company reported stronger-than-expected earnings for its fourth quarter.
    China Distance Education Hldgs Ltd (ADR) (NYSE: DL) shares surged 11.3 percent to $8.67. China Distance Education reported Q4 profit of $5.9 million on revenue of $41.7 million.
    Cytokinetics, Inc. (NASDAQ: CYTK) shares gained 11 percent to $8.05 after falling 7.05 percent on Tuesday.
    Ooma Inc (NYSE: OOMA) shares surged 8.5 percent to $10.85 as the company posted strong Q3 results.
    Nuance Communications Inc. (NASDAQ: NUAN) climbed 8 percent to $17.12 after the company reported stronger-than-expected results for its fourth quarter on Tuesday.
    American Superconductor Corporation (NASDAQ: AMSC) surged 7.8 percent to $3.59 after the company reported $8 million in D-VAR system orders.
    Thermon Group Holdings Inc (NYSE: THR) rose 6.3 percent to $24.17. William Blair upgraded Thermon Group from Market Perform to Outperform.
    Domino's Pizza, Inc. (NYSE: DPZ) surged 6.1 percent to $182.88. Nomura upgraded Domino's from Neutral to Buy.
    Xencor Inc (NASDAQ: XNCR) rose 5.9 percent to $21.17. Cantor Fitzgerald initiated coverage on Xencor with an Overweight rating.
    Idera Pharmaceuticals Inc (NASDAQ: IDRA) gained 5.1 percent to $2.28 after the company disclosed that it has been granted FDA Fast Track designation for IMO-2125.
    Regal Entertainment Group (NYSE: RGC) gained 5.1 percent to

Best Gold Stocks For 2018: Akorn, Inc.(AKRX)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Despite a lack of conviction in the market at large, some stocks posted sharp gains on Friday, and Diana Shipping (NYSE:DSX), Akorn (NASDAQ:AKRX), and Granite Construction (NYSE:GVA) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

  • [By Ben Levisohn]

    Shares of Endo International (ENDP) have tumbled 40% today after it said profits would fall well short of analyst expectations thanks, in part, to plunging generic drug prices. Leerink’s Jason Gerberry and team look for specialty pharmaceutical companies that have similar business models–and find Akorn (AKRX), Perrigo (PRGO), and Teva Pharmaceutical Industries (TEVA). They explain:

Top 10 Bank Stocks To Watch For 2018

Seasonal light volume is expected to make for a volatile week as a wealth of economic data is released regarding inflation, jobs and manufacturing following the Kansas City Federal Reserves central-banker conference in Jackson Hole, Wyo.

Stocks finished higher on the week Friday, snapping a losing streak, as the Dow Jones Industrial Average
DJIA, +0.14%
gained 0.6% for the week, the S&P 500 index
SPX, +0.17%
advanced 0.7% and the Nasdaq Composite Index
COMP, -0.09%
finished up 0.8%.

Top 10 Bank Stocks To Watch For 2018: ProShares Ultra Nasdaq Biotechnology(BIB)

Advisors’ Opinion:

  • [By Jim Robertson]

    Yesterday, our Elite Opportunity Pronewsletter suggested theProShares Ultra Nasdaq Biotechnology ETF (NASDAQ: BIB) as a way to play long term biotech bullishness with a short term caveat:

Top 10 Bank Stocks To Watch For 2018: Compass Minerals Intl Inc(CMP)

Advisors’ Opinion:

  • [By Monica Gerson]

    Compass Minerals International, Inc. (NYSE: CMP) is projected to post its quarterly earnings at $1.33 per share on revenue of $347.03 million.

    MKS Instruments, Inc. (NASDAQ: MKSI) is estimated to post its quarterly earnings at $0.33 per share on revenue of $177.19 million.

Top 10 Bank Stocks To Watch For 2018: Orocobre Limited (OROCF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

  • [By SEEKINGALPHA.COM]

    The question now is more about speed of EV implementation. On the supply side, it has been great to see LAC, Pilbara Minerals (OTCPK:PILBF) and Altura Mining (OTCPK:ALTAF) get funding, but the continued issues with Albemarle’s (NYSE:ALB) LaNegra II expansion and Orocobre (OTCPK:OROCF) ramping up to Phase 1 capacity of 17,500 tonnes/year of lithium carbonate are further evidence that lithium projects take time and have considerable execution risk.

Top 10 Bank Stocks To Watch For 2018: Akorn, Inc.(AKRX)

Advisors’ Opinion:

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

  • [By Ben Levisohn]

    Shares of Endo International (ENDP) have tumbled 40% today after it said profits would fall well short of analyst expectations thanks, in part, to plunging generic drug prices. Leerink’s Jason Gerberry and team look for specialty pharmaceutical companies that have similar business models–and find Akorn (AKRX), Perrigo (PRGO), and Teva Pharmaceutical Industries (TEVA). They explain:

  • [By Wayne Duggan]

    Akorn, Inc. (NASDAQ: AKRX) shares are up 18.2 percent on Friday after Bloomberg reported Frensius is considering a buyout bid for Akorn.

    The news came just hours after Benzinga alerted its pro subscribers to an unusually large Akorn call purchase on the options market.

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 0.62 percent. Meanwhile, top losers in the sector included Akorn, Inc. (NASDAQ: AKRX), down 17 percent, and BioDelivery Sciences International, Inc. (NASDAQ: BDSI), down 14 percent.

  • [By Dan Caplinger]

    Despite a lack of conviction in the market at large, some stocks posted sharp gains on Friday, and Diana Shipping (NYSE:DSX), Akorn (NASDAQ:AKRX), and Granite Construction (NYSE:GVA) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

Top 10 Bank Stocks To Watch For 2018: Constellation Brands Inc(STZ)

Advisors’ Opinion:

  • [By Asit Sharma]

    After four years of wildly successful expansion in its beer business, supplemented by lucrative wine portfolio additions,Constellation Brands, Inc. (NYSE:STZ) might seem to be nearing a revenue plateau.But rather than fizzling out from sheer exhaustion, the Victor, New York-based alcoholic beverage giant is likely to continue to exhibit outperformance in the near to medium term, for two simple reasons that we’ll dive into below.

  • [By Ben Levisohn]

    As the stock market has rallied sinceDonald Trump’s election in November, Constellation Brands (STZ) has basically sat it out, weighed down by concerns that a new tax plan would hurt the multinational alcoholic beverage company’s profits.

  • [By WWW.THESTREET.COM]

    In his second “Executive Decision” segment, Cramer also checked in with Rob Sands, president and CEO of Constellation Brands (STZ) , the wine and spirits maker that just posted a 24-cents-a-share earnings beat on inline revenues, but saw shares fall 7% on fears Donald Trump may impose an import tax on the company’s products, notably Corona, which hails from Mexico.

  • [By WWW.THESTREET.COM]

    Then on Thursday, Constellation Brands (STZ) reports, and as we learned yesterday, this is Cramer’s favorite liquor stock. Also on Thursday, earnings from Nike (NKE) , a battleground Cramer said he’s steering clear of, and Micron Technology (MU) , which will likely fall no matter how good its quarter.

  • [By Ben Levisohn]

    Constellation Brands (STZ) has rallied 4.7% to $169 after beating earnings forecasts and offering optimistic guidance.

    Greenbrier Cos. (GBX) has advanced 2.1% to $48.25 after getting upgraded to Buy from Neutral at BofA Merrill Lynch.

  • [By Casey Wilson]

    Constellation Brands Inc. (NYSE: STZ), which owns popular beer brands like Corona, is the latest company to realize the profit potential of the legal marijuana industry.

Top 10 Bank Stocks To Watch For 2018: NEW GOLD INC.(NGD)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market lost ground on Monday, sending major market benchmarks lower by more than half a percentage point. The Dow lost its grip on the 20,000 mark in the wake of concerns about economic growth and new U.S. immigration policy, and some believe that the broader geopolitical climate could have a negative impact on global commerce that in turn could start affecting multinational corporations’ business prospects. In addition, bad news from some individual companies weighed on the markets, and Transocean (NYSE:RIG), Rite Aid (NYSE:RAD), and New Gold (NYSEMKT:NGD) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

Top 10 Bank Stocks To Watch For 2018: Sphere 3D Corp.(ANY)

Advisors’ Opinion:

  • [By Paul Ausick]

    Sphere 3D Corp. (NASDAQ: ANY) dropped about 36% Monday to post a new 52-week low of $0.23 after closing Friday at $0.36. The 52-week high is $2.00. Volume of around 4.3 million was more than 10 times the daily average of around 390,000 shares traded. The company said today that it has received an unsolicited proposal from an unnamed company to purchase certain of Sphere 3D’s assets.

Top 10 Bank Stocks To Watch For 2018: American Assets Trust, Inc.(AAT)

Advisors’ Opinion:

  • [By Markus Aarnio]

    Owens Realty Mortgage’s competitors include American Assets Trust (AAT), Alexandria Real Estate Equities (ARE) and Boston Properties (BXP). American Assets Trust has seen five insider buy transactions and four insider sell transactions this year. American Assets Trust has a dividend yield of 2.78%. Alexandria Real Estate Equities has seen 14 insider sell transactions this year. Alexandria Real Estate Equities has a dividend yield of 4.10%. Boston Properties has seen one insider buy transaction and four insider sell transactions this year. Boston Properties has a dividend yield of 2.43%.

Top 10 Bank Stocks To Watch For 2018: MINDBODY, Inc.(MB)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Fitbit initially surging after its IPO before loosing most of its value while large capGarmin Ltd (NASDAQ: GRMN) (which hasa fitness segment)has been range bound for over a year and small cap online wellness services stockMINDBODY Inc (NASDAQ: MB) has taken off with performance starting to moderate:

  • [By Joe Tenebruso]

    Mindbody (NASDAQ:MB) provides cloud-based software solutions to the health and wellness industry: Think spas, yoga studios, and fitness classes. It’s a massive market that’s gone largely underserved — and Mindbody is working to address that need.

  • [By Peter Graham]

    A long term performance chart shows Fitbit Inc initially surging after its IPO before loosing most of its value while large capGarmin Ltd (NASDAQ: GRMN) (which hasa fitness segment)has moved back and forth from positive to negative territory and small cap online wellness services stockMINDBODY Inc (NASDAQ: MB) has taken off for the past year:

Top 10 Bank Stocks To Watch For 2018: Altisource Residential Corporation(RESI)

Advisors’ Opinion:

  • [By Mark Holder]

    Altisource Residential (NYSE: RESI  ) (NYSE: RESI  ) (NYSE: RESI  ) purchases distressed mortgage loan portfolios with a strategy to work with borrowers to modify and refinance loans to either keep them in their homes or convert the unmodified loans into renovated rental properties.